Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer

British Journal of Surgery - Tập 93 Số 10 - Trang 1215-1223 - 2006
Krzysztof Bujko1, Marek P. Nowacki2, Anna Nasierowska‐Guttmejer3, Wojciech Michalski4, Marek Bębenek5, M. Kryj6
1Department of Radiotherapy, Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland
2Department of Colorectal Cancer, Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland
3Department of Pathology, Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland
4Department of Biostatistics, Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, Poland
5Department of Surgery, Silesian Oncological Centre, Wroclaw, Poland
6Department of Surgery, Maria Sklodowska-Curie Memorial Cancer Centre, Gliwice, Poland

Tóm tắt

Abstract Background

Neoadjuvant chemoradiotherapy does not alter anal sphincter preservation or postoperative complications compared with short-course radiotherapy alone in patients with clinical stage T3 or T4 resectable rectal cancer. The aim of this study was to compare survival, local control and late toxicity in the two treatment groups.

Methods

The study randomized 312 patients to receive either preoperative irradiation (25 Gy in five fractions of 5 Gy) and surgery within 7 days or chemoradiation (50·4 Gy in 28 fractions of 1·8 Gy, bolus 5-fluorouracil and leucovorin) and surgery 4–6 weeks later. The median follow-up of living patients was 48 (range 31–69) months.

Results

Early radiation toxicity was higher in the chemoradiation group (18·2 versus 3·2 per cent; P < 0·001). The actuarial 4-year overall survival was 67·2 per cent in the short-course group and 66·2 per cent in the chemoradiation group (P = 0·960). Disease-free survival was 58·4 versus 55·6 per cent (P = 0·820), crude incidence of local recurrence was 9·0 versus 14·2 per cent (P = 0·170) and severe late toxicity was 10·1 versus 7·1 per cent (P = 0·360) respectively.

Conclusion

Neoadjuvant chemoradiation did not increase survival, local control or late toxicity compared with short-course radiotherapy alone.

Từ khóa


Tài liệu tham khảo

Pahlman, 1985, Pre- versus postoperative radiotherapy in rectal carcinoma: an interim report from a randomized multicentre trial, Br J Surg, 72, 961, 10.1002/bjs.1800721209

Frykholm, 1993, Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects, Dis Colon Rectum, 36, 564, 10.1007/BF02049863

Glimelius, 1997, Radiotherapy in addition to radical surgery in rectal cancer: evidence for a dose–response effect favoring preoperative treatment, Int J Radiat Oncol Biol Phys, 37, 281, 10.1016/S0360-3016(96)00510-X

Sauer, 2004, Preoperative versus postoperative chemoradiotherapy for rectal cancer, N Engl J Med, 351, 1731, 10.1056/NEJMoa040694

Stockholm Rectal Cancer Study Group, 1990, Preoperative short-term radiation therapy in operable rectal carcinoma: a prospective randomized trial, Cancer, 66, 49, 10.1002/1097-0142(19900701)66:1<49::AID-CNCR2820660111>3.0.CO;2-1

Stockholm Rectal Cancer Study Group, 1996, Randomized study on preoperative radiotherapy in rectal carcinoma, Ann Surg Oncol, 3, 423, 10.1007/BF02305759

Swedish Rectal Cancer Trial, 1997, Improved survival with preoperative radiotherapy in resectable rectal cancer, N Engl J Med, 336, 980, 10.1056/NEJM199704033361402

Kapiteijn, 2001, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N Engl J Med, 345, 638, 10.1056/NEJMoa010580

Bosset, 2005, Preoperative radiation (Preop RT) in rectal cancer: effect and timing of additional chemotherapy (CT) 5-year results of the EORTC 22921 trial. 2005 ASCO Annual Meeting Proc, J Clin Oncol, 23, S247, 10.1200/jco.2005.23.16_suppl.3505

Gérard, 2005, Preoperative concurrent chemoradiotherapy (CT–RT) improves local control in T3–4 rectal cancers; results of the FFCD 9203 randomized trial, Int J Rad Oncol Biol Phys, 63, S2, 10.1016/j.ijrobp.2005.07.010

Marijnen, 2004, Long term results, toxicity and quality of life in the TME trial, Radiother Oncol, 73, S127, 10.1016/S0167-8140(04)82150-9

Birgisson, 2005, Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial, J Clin Oncol, 23, 8697, 10.1200/JCO.2005.02.9017

Swedish Rectal Cancer Trial, 1993, Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma, Br J Surg, 80, 1333, 10.1002/bjs.1800801040

Marijnen, 2002, Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicentre randomized trial, J Clin Oncol, 20, 817, 10.1200/JCO.2002.20.3.817

Bujko, 2004, Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy, Radiother Oncol, 72, 15, 10.1016/j.radonc.2003.12.006

Bosset, 2004, Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance, Eur J Cancer, 40, 219, 10.1016/j.ejca.2003.09.032

Minsky, 1997, Adjuvant therapy for rectal cancer—a good first step, N Engl J Med, 336, 1016, 10.1056/NEJM199704033361410

Valentini, 2005, The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for a European Consensus, Radiother Oncol, 76, 241, 10.1016/j.radonc.2005.07.001

Bujko, 2005, Postoperative complications in patients irradiated pre-operatively for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. chemoradiation, Colorectal Dis, 7, 410, 10.1111/j.1463-1318.2005.00796.x

Chmielik, 2006, Distal intramural spread of rectal cancer following preoperative radiotherapy: the results of a multicentre randomized clinical study, Int J Radiat Oncol Biol Phys, 65, 182, 10.1016/j.ijrobp.2005.11.039

Minsky, 1998, Textbook of Radiation Oncology, 686

Cox, 1995, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC), Int J Radiat Oncol Biol Phys, 31, 1341, 10.1016/0360-3016(95)00060-C

1995, LENT SOMA tables, Radiother Oncol, 35, 17, 10.1016/0167-8140(95)90055-1

Graf, 1997, Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients, Radiother Oncol, 43, 133, 10.1016/S0167-8140(96)01867-1

Wibe, 2004, Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection, Dis Colon Rectum, 47, 48, 10.1007/s10350-003-0012-y

Francois, 1999, Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial, J Clin Oncol, 17, 2396, 10.1200/JCO.1999.17.8.2396

Gerard, 2004, Improved sphincter preservation in low rectal cancer with high dose preoperative radiotherapy: the Lyon R96-02 randomized trial, J Clin Oncol, 22, 2404, 10.1200/JCO.2004.08.170

Suit, 1964, Intact tumor cells in irradiated tissue, Arch Pathol, 78, 648